Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Orally Administered Sodium Propionate to Treat and Prevent Diabetes

NCT01692002 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT01692002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01692002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Orally Administered Sodium Propionate to Treat and Prevent Diabetes
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Terminated
Start date
January 31, 2013
Completion date
August 31, 2019
Enrollment
6 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus